Zobrazeno 1 - 10
of 177
pro vyhledávání: '"D. Warot"'
Autor:
Edward G. Singleton, Christine Notides, Stephen J. Heishman, Florence Vorspan, D. Warot, Ivan Berlin
Publikováno v:
European Addiction Research. 11:62-68
Objectives: (1) To assess the factorial structure, reliability and validity of the French language version of the Tobacco Craving Questionnaire (TCQ), a multidimensional, self-report instrument evaluating tobacco craving, to allow its use in French-s
Autor:
Chantal Bélorgey, Yannick Plétan, Jean-Marie Goehrs, F. Berger, P.-H. Bertoye, N. Brion, A. Buntix, H. Caplain, C. Caulin, S. Courcier-Duplantier, V. Daurat, J.-P. Demarez, B. Diquet, M. Echemann, C. Funck-Brentano, V. Lamarque, S. Laurent, C. Libersa, C. Marey, N. Moore, A. Patat, J.-L. Pinquier, J.-C. Reynier, A. Sawaya, C. Sibenaler, N. Simon, D. Tremblay, P. Vella, D. Warot
Publikováno v:
Therapies. 59:337-347
The European Directive on clinical trials of medicinal products will fall within the scope of the legislation of Member States on 1 May 2004. In France, this adaptation will be carried out by a public health bill concerning, among other things, the r
Autor:
Chantal Bélorgey, Yannick Plétan, Jean-Marie Goehrs, F. Berger, P.-H. Bertoye, N. Brion, A. Buntix, H. Caplain, C. Caulin, S. Courcier-Duplantier, V. Daurat, J.-P. Demarez, B. Diquet, M. Echemann, C. Funck-Brentano, V. Lamarque, S. Laurent, C. Libersa, C. Marey, N. Moore, A. Patat, J.-L. Pinquier, J.-C. Reynier, A. Sawaya, C. Sibenaler, N. Simon, D. Tremblay, P. Vella, D. Warot
Publikováno v:
Therapies. 59:329-336
Resume La Directive Europeenne Essais Cliniques des medicaments devra entrer dans le droit des etats membres le 1 er mai 2004. En France, c’est par un projet de loi de Sante Publique portant entre autres sur la reforme de l’actuelle loi Huriet-Se
Autor:
Guy Aymard, Philippe Lechat, Christine Alquier, Marie Emmanuelle Le Guern, Pierre Démolis, B. Diquet, D. Warot, Jean François Giudicelli
Publikováno v:
Pharmacology & Toxicology. 92:279-286
To determine the pharmacokinetic, subjective effects of a single 20 mg dose of nefopam administered either intravenously or orally in healthy volunteers, twenty-four healthy Caucasian men received 20 mg nefopam orally+placebo intravenous infusion and
Autor:
Jean-Pierre Lépine, Eric Hispard, Samir Tilikete, Henri-Jean Aubin, Sylvain Dally, Donata Marra, Christine Notides, Ivan Berlin, D. Warot, Christine Payan
Publikováno v:
Alcoholism: Clinical and Experimental Research. 26:1545-1552
Background: Few medications have been proved to be effective in preventing relapse in alcoholism. The mesolimbic dopamine system is known to play an important role in alcohol dependence. Amisulpride, a substituted benzamide, seems to facilitate dopam
Autor:
Eric Acquaviva, Philippe Lechat, D. Warot, Benoit Labarthe, Guy Aymard, Isabelle Peyron, Ivan Berlin, Mayeule Legrand, B. Diquet
Publikováno v:
European Journal of Clinical Pharmacology. 57:447-455
Objective: To determine the cardiovascular, subjective effects and potential of abuse liability of single dose (–) ephedrine (E) administered orally (50 mg) or intranasally (10 mg and 5 mg). Methods: Sixteen healthy Caucasian men with no history of
Autor:
V. Corbrion Archer, D. Warot, O. Chosidow, Bertrand Diquet, Alain J. Puech, Jean-Claude Levron, Bénédicte Lebrun-Vignes
Publikováno v:
British Journal of Clinical Pharmacology. 51:443-450
Aims Itraconazole is a potent inhibitor of CYP3A4 activity and is often used in combination with corticosteroids. Since the latter are partly metabolized by CYP3A4, we studied the interaction between itraconazole, prednisone and methylprednisolone in
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 744:25-31
A high-performance liquid chromatography procedure for the determination of ephedrine and norephedrine using fluorimetric detection in plasma samples is described. A double liquid–liquid extraction was performed, followed by derivatization with 9-f
Publikováno v:
Drug and Alcohol Dependence. 45:177-183
The main metrological characteristics of a French version of the 49-item addiction research center inventory (ARCI) were evaluated using data collected in three controlled studies in healthy subjects. An analysis of variance showed no study effect, s
Publikováno v:
The Journal of Clinical Pharmacology. 36:942-950
Befloxatone is a new reversible and selective monoamine oxidase (MAO-A) inhibitor that has been shown to have antidepressant activity in various animal models. To assess the effects of single oral doses of befloxatone (5, 10, and 20 mg) on psychomoto